SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001113148-22-000012
Filing Date
2022-05-03
Accepted
2022-05-03 15:50:15
Documents
60
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q infi-20220331.htm   iXBRL 10-Q 788622
2 EX-31.1 ex-311q12022.htm EX-31.1 9064
3 EX-31.2 ex-312q12022.htm EX-31.2 9486
4 EX-32.1 ex-321q12022.htm EX-32.1 4364
5 EX-32.2 ex-322q12022.htm EX-32.2 4395
  Complete submission text file 0001113148-22-000012.txt   4278450

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT infi-20220331.xsd EX-101.SCH 43175
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT infi-20220331_cal.xml EX-101.CAL 63395
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT infi-20220331_def.xml EX-101.DEF 135887
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT infi-20220331_lab.xml EX-101.LAB 455054
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT infi-20220331_pre.xml EX-101.PRE 263401
54 EXTRACTED XBRL INSTANCE DOCUMENT infi-20220331_htm.xml XML 591664
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31141 | Film No.: 22886613
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences